This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters

Avicanna Inc. (TSX: AVCN, OTCQX: AVCNF, Forum) is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ [Open in your browser]( [Alert] [Logo] --------------------------------------------------------------- [This Cannabis Co. Earned a 100% Revenue Increase Over 3 Consecutive Quarters]( Avicanna Inc. ([TSX: AVCN]( [OTCQX: AVCNF]( [Forum]( is a diversified and vertically integrated Canadian biopharmaceutical Company that is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. AVCN's research is mainly conducted at its R&D headquarters in Toronto's Johnson & Johnson Innovation Centre in collaboration with leading Canadian academic and medical institutions. Its product lines include: the derma cosmetic Pura H&W offering, as well as its RHO Phyto medical cannabis line, which is available across Canada in partnership with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart. VIDEO | Avicanna Profitability 2021 The company manages its own supply chain from cultivation and extraction through its two majority-owned subsidiaries – Sativa Nativa SAS and Santa Marta Golden Hemp SAS in Santa Marta, Colombia. Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. In this video, Avicanna's Chief Executive Officer Aras Azadian offers a corporate update for shareholders, dicing into his company's recent efforts to develop, manufacture, and commercialize plant-derived cannabinoid-based products for its pharmaceutical pipeline. [LEARN MORE]( FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing.  The advertiser featured in this Stockhouse Publishing Ltd. Alert has paid a fee in cash or stock not exceeding $5,000 to have their corporate, marketing, and promotional, information and activities featured. The information shown is solely the responsibility of the advertiser [Avicanna Inc.], not Stockhouse Publishing Ltd, whose only function was as a supplier of media facilities. Any information provided is not to be construed as a recommendation or suggestion or offer to buy or sell securities. Your information is shared only with the advertiser featured in this Alert and will not be sold or rented to any other third party. The advertiser may contact you from time to time with updates. You opted in to receive this Alert, which are sent on a request-only basis. To advertise, please contact us at sales@stockhouse.com. --------------------------------------------------------------- [facebook]( [twitter]( [LinkedIn]( [stockhouse]( Stockhouse Publishing Ltd. | 1185 West Georgia Street, Suite 1625 | Vancouver | BC | V6E 4E6 | CA This email was sent to you by Stockhouse Publishing Ltd. because you consented to receive messages from us. You may [manage your subscription]( preferences at any time. You may contact our email compliance officer at compliance@stockhouse.com